Pharmacological Adjuncts for Use in Smoking Cessation - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

Pharmacological Adjuncts for Use in Smoking Cessation

Description:

Why Combine Behavior Therapy and Medication? ... Treatment integrity measures showed evidence of therapy adherence and discriminability. ... – PowerPoint PPT presentation

Number of Views:43
Avg rating:3.0/5.0
Slides: 26
Provided by: nida2
Category:

less

Transcript and Presenter's Notes

Title: Pharmacological Adjuncts for Use in Smoking Cessation


1
Cognitive Behavioral Therapy and Naltrexone for
Cocaine Dependence
  • Joy M. Schmitz, Ph.D.
  • Substance Abuse Research Center
  • University of Texas Medical School
  • Houston
  • Supported by NIDA (DA-09262, DA-6143, DA-15801)

APA 2004
2
Why Combine Behavior Therapy and Medication?
  • For the treatment of cocaine dependence, little
    benefit from pharmacotherapy or psychotherapy
    alone
  • Each form of treatment may address distinct
    symptom areas, providing broader coverage
  • Offset the potential drawbacks associated with
    either treatment
  • Patient heterogeneity leads to differential
    response to treatment

3
(No Transcript)
4
Study Design
Pharmacotherapy (Naltrexone)
50 mg
0 mg
Drug Counseling (DC)
Psycho- Therapy
Relapse Prevention (RP)
5
Pharmacotherapy
  • Naltrexone
  • Opiate antagonists attenuate cocaine's euphoric
    effects (Bain Kornetsky, 1986 Kosten et al.,
    1992 Hubbell Reid, 1995 Reid et al., 1993
    1996)
  • Opiate antagonists decrease cocaine
    self-administration (DeVry et al., 1989 Mello et
    al., 1990 Ramsey vanRee, 1991 Corrigall
    Coen, 1991 Reid et al., 1995 1996 1997)
  • Opiate antagonist treatment associated with lower
    rates of cocaine use (Kosten et al., 1989 Rosen
    Kosten, 1991)

6
Psychotherapy
  • Relapse Prevention (RP)
  • Coping Skills Relapse Prevention Theory (Marlatt
    Gordon, 1985)
  • Components include functional analysis of
    situational factors associated with craving or
    drug use, self-monitoring and specific home
    practice exercises, general lifestyle
    modifications, handling a lapse training.
  • Drug Counseling (DC)
  • General education, nondirective support,
    encouragement for abstinence-oriented behaviors
    (Woody et al., 1983 Luborsky et al., 1982)
  • Components include assessment of problem areas
    (e.g., health, family, vocation), education about
    recovery, crisis management.

7
Therapy Adherence
8
(No Transcript)
9
Retention
Log Rank Statistic 1.72, df 3, p .63.
10
Cocaine Use

Therapy x Medication x Time F (2, 60) 3.69, p
lt 0.03.
11
Does homework compliance predict outcome?
  • Cognitive-behavioral psychotherapies are based on
    the premise that clients are more likely to
    improve if they apply skills learned in treatment
    to situations outside treatment (i.e., homework).
  • The relationship between homework compliance and
    treatment outcome is reliable and robust across
    different client problems (Kazantzis et al.,
    2002).

12
CBT Homework
  • Examples
  • Self-monitoring
  • Trigger sheet
  • Recognizing assertiveness
  • Goal setting
  • Coping records
  • Awareness of problem thinking

13
Motivation and homework completion on cocaine use
during treatment
14
Conclusions
  • In cocaine-dependent patients, the combination of
    naltrexone 50 mg and Relapse Prevention therapy
    was effective in reducing cocaine use.
  • Treatment integrity measures showed evidence of
    therapy adherence and discriminability.
  • For CBT, a positive relationship between
    homework compliance and cocaine outcome was
    found. Motivation to change affected the
    direction of this relationship.
  • Need to replicate and extend to determine the
    robustness of this treatment.

15
Naltrexone Studies
  • Naltrexone and relapse prevention treatment for
    cocaine-dependent patients
  • Naltrexone and relapse prevention treatment for
    cocaine-alcohol dependent patients

16
Study Design
Pharmacotherapy (Naltrexone)
50 mg
0 mg
Drug Counseling (DC)
Psycho- Therapy
Relapse Prevention (RP)
17
TABLE 1 Characteristics of Participants in Each
Treatment Group  
  a Attended at least six weeks of treatment.
18
Retention
Log Rank (df 3) 3.62, ns.
19
Cocaine Use
Time x Therapy F (11, 332) 2.09, p lt 0.02.
20
Conclusions
  • Naltrexone did not reduce cocaine or alcohol use
    in this sample of dually-dependent patients.
  • Patients receiving Drug Counseling used less
    cocaine over time than those receiving Relapse
    Prevention.
  • Naltrexones lack of efficacy in treating this
    type of comorbidity, also reported by Hersh et
    al., 1998, may be due to greater impairment in
    this population.

21
Combined Treatment for Cocaine-Alcohol
Dependence R01 DA15801
Pharmacotherapy (Naltrexone)
100 mg
0 mg
Relapse Prevention (RP)
Behavior Therapy
RP Conting. Manag. Proc
22
Results cocaine abstinent Ss
Pettinati et al, 2004
Men
23
Conclusions
  • Among cocaine dependent patients
  • Naltrexone 50mg
  • reduced cocaine use
  • was well tolerated
  • worked best with CBT
  • Among cocaine-alcohol dependent patients
  • Naltrexone 50 mg
  • ineffective with/without CBT

24
Future Considerations
  • Optimal dosing
  • Combination pharmacotherapy
  • Relapse prevention vs abstinence initiation
  • Enhancing compliance, increasing motivation
  • Patients conceptualization of behavior therapy
    medication

25
Treatment expectancies
Write a Comment
User Comments (0)
About PowerShow.com